{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T05:10:47Z","timestamp":1789881047119,"version":"4.0.1"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","physicamedica.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physica Medica"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ejmp.2025.105063","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T21:35:18Z","timestamp":1754688918000},"page":"105063","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Dose escalation in pediatric pelvic Ewing\u2019s Sarcoma: Insights from a national treatment planning exercise"],"prefix":"10.1016","volume":"137","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7332-3383","authenticated-orcid":false,"given":"G.","family":"Beldjoudi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Goudjil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6095-4397","authenticated-orcid":false,"given":"C.","family":"Lafond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Raucoules","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Moignier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8143-9992","authenticated-orcid":false,"given":"D.","family":"Maneval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Bartau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Hangard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Trauchessec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Anthonipillai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Gehin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8994-5999","authenticated-orcid":false,"given":"T.","family":"Lacornerie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Claude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4270-5370","authenticated-orcid":false,"given":"L.","family":"Ollivier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmp.2025.105063_b0005","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1200\/JCO.2014.59.5256","article-title":"Ewing Sarcoma: current management and future approaches through collaboration","volume":"33","author":"Gaspar","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejmp.2025.105063_b0010","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/pbc.10472","article-title":"Ewing sarcoma: radiation dose and target volume","volume":"42","author":"Donaldson","year":"2004","journal-title":"Pediatr Blood Cancer"},{"issue":"61","key":"10.1016\/j.ejmp.2025.105063_b0015","first-page":"128","article-title":"Can postoperative radiotherapy be omitted in localised standard-risk Ewing sarcoma? An observational study of the Euro-E.W.I.N.G group","volume":"2016","author":"Foulon","year":"1990","journal-title":"Eur J Cancer Oxf Engl"},{"key":"10.1016\/j.ejmp.2025.105063_b0020","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1054\/bjoc.2001.2150","article-title":"Prognostic factors in localized Ewing\u2019s tumours and peripheral neuroectodermal tumours: the third study of the French Society of Paediatric Oncology (EW88 study)","volume":"85","author":"Oberlin","year":"2001","journal-title":"Br J Cancer"},{"issue":"173","key":"10.1016\/j.ejmp.2025.105063_b0025","first-page":"71","article-title":"Paediatric Strategy Forum for medicinal product development of multi-targeted kinase inhibitors in bone sarcomas: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration","volume":"2022","author":"Pearson","year":"1990","journal-title":"Eur J Cancer Oxf Engl"},{"key":"10.1016\/j.ejmp.2025.105063_b0030","doi-asserted-by":"crossref","first-page":"155","DOI":"10.6004\/jnccn.2017.0017","article-title":"NCCN guidelines insights: bone cancer, Version 2.2017","volume":"15","author":"Biermann","year":"2017","journal-title":"J Natl Compr Cancer Netw JNCCN"},{"key":"10.1016\/j.ejmp.2025.105063_b0035","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/j.annonc.2021.08.1995","article-title":"Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"32","author":"Strauss","year":"2021","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"10.1016\/j.ejmp.2025.105063_b0040","doi-asserted-by":"crossref","first-page":"5685","DOI":"10.1118\/1.4963219","article-title":"Evaluation of the dose calculation accuracy for small fields defined by jaw or MLC for AAA and Acuros XB algorithms","volume":"43","author":"Fogliata","year":"2016","journal-title":"Med Phys"},{"key":"10.1016\/j.ejmp.2025.105063_b0045","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ijrobp.2017.05.014","article-title":"Consensus guidelines for implementing pencil-beam scanning proton therapy for thoracic malignancies on behalf of the PTCOG thoracic and lymphoma subcommittee","volume":"99","author":"Chang","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejmp.2025.105063_b0050","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s13014-015-0569-3","article-title":"A dose-volume histogram based decision-support system for dosimetric comparison of radiotherapy treatment plans","volume":"10","author":"Alfonso","year":"2015","journal-title":"Radiat Oncol Lond Engl"},{"key":"10.1016\/j.ejmp.2025.105063_b0055","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ijrobp.2023.09.005","article-title":"A user\u2019s guide and summary of pediatric normal tissue effects in the clinic (PENTEC): radiation dose-volume response for adverse effects after childhood cancer therapy and future directions","volume":"119","author":"Constine","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejmp.2025.105063_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110270","article-title":"Comprehensive radiotherapy for pediatric Ewing Sarcoma: Outcomes of a prospective proton study","volume":"195","author":"Bronk","year":"2024","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"10.1016\/j.ejmp.2025.105063_b0065","series-title":"SEER cancer statistics review, 1975-2018","author":"Howlader","year":"2021"},{"key":"10.1016\/j.ejmp.2025.105063_b0070","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.radonc.2020.05.038","article-title":"Organ at risk delineation for radiation therapy clinical trials: Global Harmonization Group consensus guidelines","volume":"150","author":"Mir","year":"2020","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"10.1016\/j.ejmp.2025.105063_b0075","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.ijrobp.2020.04.043","article-title":"Treatment outcomes after proton therapy for Ewing sarcoma of the pelvis","volume":"107","author":"Uezono","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejmp.2025.105063_b0080","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/jnci\/djq238","article-title":"Subsequent neoplasms in 5-year survivors of childhood cancer: the childhood cancer survivor study","volume":"102","author":"Friedman","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejmp.2025.105063_b0085","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.ijrobp.2018.12.021","article-title":"Insurance approval for proton beam therapy and its impact on delays in treatment","volume":"104","author":"Gupta","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejmp.2025.105063_b0090","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.ijrobp.2019.04.007","article-title":"The insurance approval process for proton beam therapy must change: prior authorization is crippling access to appropriate health care","volume":"104","author":"Yu","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejmp.2025.105063_b0095","doi-asserted-by":"crossref","first-page":"E598","DOI":"10.1002\/lary.28458","article-title":"Proton radiotherapy and treatment delay in head and neck squamous cell carcinoma","volume":"130","author":"Jin","year":"2020","journal-title":"Laryngoscope"}],"container-title":["Physica Medica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1120179725001735?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1120179725001735?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T22:53:21Z","timestamp":1762815201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1120179725001735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":19,"alternative-id":["S1120179725001735"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmp.2025.105063","relation":{},"ISSN":["1120-1797"],"issn-type":[{"value":"1120-1797","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dose escalation in pediatric pelvic Ewing\u2019s Sarcoma: Insights from a national treatment planning exercise","name":"articletitle","label":"Article Title"},{"value":"Physica Medica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmp.2025.105063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Associazione Italiana di Fisica Medica e Sanitaria. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105063"}}